BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 28657950)

  • 21. Association of the Hospital Readmissions Reduction Program With Mortality Among Medicare Beneficiaries Hospitalized for Heart Failure, Acute Myocardial Infarction, and Pneumonia.
    Wadhera RK; Joynt Maddox KE; Wasfy JH; Haneuse S; Shen C; Yeh RW
    JAMA; 2018 Dec; 320(24):2542-2552. PubMed ID: 30575880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends in readmission rates for safety net hospitals and non-safety net hospitals in the era of the US Hospital Readmission Reduction Program: a retrospective time series analysis using Medicare administrative claims data from 2008 to 2015.
    Salerno AM; Horwitz LI; Kwon JY; Herrin J; Grady JN; Lin Z; Ross JS; Bernheim SM
    BMJ Open; 2017 Jul; 7(7):e016149. PubMed ID: 28710221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in coding of pneumonia and impact on the Hospital Readmission Reduction Program.
    Buxbaum JD; Lindenauer PK; Cooke CR; Nuliyalu U; Ryan AM
    Health Serv Res; 2019 Dec; 54(6):1326-1334. PubMed ID: 31602637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Impact of the Medicare Hospital Readmission Reduction Program in New York State.
    McGarry BE; Blankley AA; Li Y
    Med Care; 2016 Feb; 54(2):162-71. PubMed ID: 26761728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact Of Medicare Readmissions Penalties On Targeted Surgical Conditions.
    Chhabra KR; Ibrahim AM; Thumma JR; Ryan AM; Dimick JB
    Health Aff (Millwood); 2019 Jul; 38(7):1207-1215. PubMed ID: 31260354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How Have 30-Day Readmission Penalties Affected Racial Disparities in Readmissions?: an Analysis from 2007 to 2014 in Five US States.
    Kaplan CM; Thompson MP; Waters TM
    J Gen Intern Med; 2019 Jun; 34(6):878-883. PubMed ID: 30737680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Readmission rates in not-for-profit vs. proprietary hospitals before and after the hospital readmission reduction program implementation.
    Birmingham LE; Oglesby WH
    BMC Health Serv Res; 2018 Jan; 18(1):31. PubMed ID: 29351776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temporal Trends in Racial Differences in 30-Day Readmission and Mortality Rates After Acute Myocardial Infarction Among Medicare Beneficiaries.
    Pandey A; Keshvani N; Khera R; Lu D; Vaduganathan M; Joynt Maddox KE; Das SR; Kumbhani DJ; Goyal A; Girotra S; Chan P; Fonarow GC; Matsouaka R; Wang TY; de Lemos JA
    JAMA Cardiol; 2020 Feb; 5(2):136-145. PubMed ID: 31913411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Impact of the Hospital Readmissions Reduction Program across Insurance Types in California.
    Zingmond DS; Liang LJ; Parikh P; Escarce JJ
    Health Serv Res; 2018 Dec; 53(6):4403-4415. PubMed ID: 29740816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cirrhosis as a Comorbidity in Conditions Subject to the Hospital Readmissions Reduction Program.
    Rosenblatt R; Cohen-Mekelburg S; Shen N; Tafesh Z; Lucero C; Kumar S; Fortune B; Liu SY; Brown R; Jesudian A
    Am J Gastroenterol; 2019 Sep; 114(9):1488-1495. PubMed ID: 31180921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Readmissions performance and penalty experience of safety-net hospitals under Medicare's Hospital Readmissions Reduction Program.
    Banerjee S; Paasche-Orlow MK; McCormick D; Lin MY; Hanchate AD
    BMC Health Serv Res; 2022 Mar; 22(1):338. PubMed ID: 35287693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreases In Readmissions Credited To Medicare's Program To Reduce Hospital Readmissions Have Been Overstated.
    Ody C; Msall L; Dafny LS; Grabowski DC; Cutler DM
    Health Aff (Millwood); 2019 Jan; 38(1):36-43. PubMed ID: 30615522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reliability of 30-Day Readmission Measures Used in the Hospital Readmission Reduction Program.
    Thompson MP; Kaplan CM; Cao Y; Bazzoli GJ; Waters TM
    Health Serv Res; 2016 Dec; 51(6):2095-2114. PubMed ID: 27766634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accounting for the Growth of Observation Stays in the Assessment of Medicare's Hospital Readmissions Reduction Program.
    Sabbatini AK; Joynt-Maddox KE; Liao JM; Basu A; Parrish C; Kreuter W; Wright B
    JAMA Netw Open; 2022 Nov; 5(11):e2242587. PubMed ID: 36394872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Hospital Readmissions Reduction Program-learning from failure of a healthcare policy.
    Gupta A; Fonarow GC
    Eur J Heart Fail; 2018 Aug; 20(8):1169-1174. PubMed ID: 29791084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A news media analysis of the economic and reputational penalties of the hospital readmissions reduction program.
    Winborn MS; Alencherril J; Pagán JA
    Inquiry; 2014; 51():. PubMed ID: 25500753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association Between Hospitals' Engagement in Value-Based Reforms and Readmission Reduction in the Hospital Readmission Reduction Program.
    Ryan AM; Krinsky S; Adler-Milstein J; Damberg CL; Maurer KA; Hollingsworth JM
    JAMA Intern Med; 2017 Jun; 177(6):862-868. PubMed ID: 28395006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Indication for Lower Extremity Revascularization and Hospital Profiling of Readmissions.
    Gonzalez AA; Cruz CG; Dev S; Osborne NH
    Ann Vasc Surg; 2016 Aug; 35():130-7. PubMed ID: 27311949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Stratification by Dual Enrollment Status With Financial Penalties in the Hospital Readmissions Reduction Program.
    Joynt Maddox KE; Reidhead M; Qi AC; Nerenz DR
    JAMA Intern Med; 2019 Jun; 179(6):769-776. PubMed ID: 30985863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of the New Peer Group-Stratified Method With the Reclassification of Penalty Status in the Hospital Readmission Reduction Program.
    McCarthy CP; Vaduganathan M; Patel KV; Lalani HS; Ayers C; Bhatt DL; Januzzi JL; de Lemos JA; Yancy C; Fonarow GC; Pandey A
    JAMA Netw Open; 2019 Apr; 2(4):e192987. PubMed ID: 31026033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.